Effectiveness of Various Drug Carriers in Controlled Release Formulations of Raloxifene HCl Prepared by Melt Mixing

Dimitrios      Bikiaris; Vassilios      Karavelidis; Evangelos      Karavas

Abstract

In the present study solid dispersions of Raloxifene HCl were prepared by melt mixing. As drug carriers, biodegradable/ biocompatible aliphatic polyesters were used. These formulations were compared to those based on extensively used drug carriers such as PEG and Gelucire 50/13. The used aliphatic polyesters namely poly(propylene succinate) (PPSu) and poly(propylene adipate) (PPAd) were prepared by melt polycondensation. The polyesters have melting points close to human body temperature and were used for first time as drug carries. Polymer cytocompatibility based on HUVEC cells viability in the presence of increasing concentrations of polymer was investigated and it was found that PPSu and PPAd exhibit comparable cytocompatibility with poly(dl-lactide). The physical state of solid dispersions was evaluated by FTIR, SEM and XRD techniques. In all cases the interactions between drug and carriers are limited and thus the dispersed drug was mainly in the crystalline state. SEM revealed that the particles size of the dispersed drug increases with increasing the drug amount. The release behavior of the drug is affected from both the drug amount and the kind of the used carrier. The drug is released almost immediately from PEG formulations while Gelucire results in sustained release. In formulations that polyesters were used as drug carriers the release is slower.

Keywords: Raloxifene HCl, aliphatic polyesters, biocompatible polymers, PEG, Gelucire, melt mixing

Rights & Permissions Print Cite

Current Drug Delivery

Title: Effectiveness of Various Drug Carriers in Controlled Release Formulations of Raloxifene HCl Prepared by Melt Mixing

Volume: 6 Issue: 5

Author(s): Dimitrios Bikiaris, Vassilios Karavelidis and Evangelos Karavas

Affiliation:

Keywords: Raloxifene HCl, aliphatic polyesters, biocompatible polymers, PEG, Gelucire, melt mixing

Abstract: In the present study solid dispersions of Raloxifene HCl were prepared by melt mixing. As drug carriers, biodegradable/ biocompatible aliphatic polyesters were used. These formulations were compared to those based on extensively used drug carriers such as PEG and Gelucire 50/13. The used aliphatic polyesters namely poly(propylene succinate) (PPSu) and poly(propylene adipate) (PPAd) were prepared by melt polycondensation. The polyesters have melting points close to human body temperature and were used for first time as drug carries. Polymer cytocompatibility based on HUVEC cells viability in the presence of increasing concentrations of polymer was investigated and it was found that PPSu and PPAd exhibit comparable cytocompatibility with poly(dl-lactide). The physical state of solid dispersions was evaluated by FTIR, SEM and XRD techniques. In all cases the interactions between drug and carriers are limited and thus the dispersed drug was mainly in the crystalline state. SEM revealed that the particles size of the dispersed drug increases with increasing the drug amount. The release behavior of the drug is affected from both the drug amount and the kind of the used carrier. The drug is released almost immediately from PEG formulations while Gelucire results in sustained release. In formulations that polyesters were used as drug carriers the release is slower.

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Bikiaris Dimitrios, Karavelidis Vassilios and Karavas Evangelos, Effectiveness of Various Drug Carriers in Controlled Release Formulations of Raloxifene HCl Prepared by Melt Mixing, Current Drug Delivery 2009; 6 (5) . https://dx.doi.org/10.2174/156720109789941632

DOI https://dx.doi.org/10.2174/156720109789941632	Print ISSN 1567-2018
Publisher Name Bentham Science Publisher	Online ISSN 1875-5704

About this journal

Call for Papers in Thematic Issues

Submission closes on : 07 June, 2024

Advances of natural products, bio-actives and novel drug delivery system against emerging viral infections

Due to the increasing prevalence of viral infections and the ability of these human pathogens to develop resistance to current treatment strategies, there is a great need to find and develop new compounds to combat them. These molecules must have low toxicity, specific activity and high bioavailability. The most suitable ...read more

Guest Editor(s): Munish Garg

Submission closes on : 24 July, 2024

Electrospun Fibers as Drug Delivery Systems

In recent years, electrospun fibers have attracted considerable attention as potential platforms for drug delivery due to their distinctive properties and adaptability. These fibers feature a notable surface area-to-volume ratio and can be intentionally designed with high porosity, facilitating an increased capacity for drug loading and rendering them suitable for ...read more

Guest Editor(s): Luis Jes?s Villarreal-G?mez

Submission closes on : 31 May, 2024

Emerging Nanotherapeutics for Mitigation of Neurodegenerative Disorders

Conditions affecting the central nervous system (CNS) present a significant hurdle due to limited access of both treatments and diagnostic tools for the brain. The blood-brain barrier (BBB) acts as a barrier, restricting the passage of molecules from the bloodstream into the brain. The most formidable challenge facing scientists is ...read more

Guest Editor(s): Rahul Shukla

Submission closes on : 30 June, 2024

Nanotechnology Based Chemotherapy for the treatment of Head & Neck Cancer

The escalating recurrence rates observed in Head and Neck cancer, particularly within the chemo-therapeutically treated cohort (50-60%), can be attributed to the non-selective nature of current anticancer drug delivery modalities. In this context, nanotechnology-based drug delivery systems emerge as a promising avenue for achieving precise localization of therapeutic agents to ...read more

Guest Editor(s): Saurabh Srivastava